MOLINA HEALTHCARE, INC. Fair Value Disclosure
| Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Corporate debt securities | $ | 2,465 | $ | — | $ | 2,465 | $ | — | |||||||||||||||
| Mortgage-backed securities | 953 | — | 953 | — | |||||||||||||||||||
| Asset-backed securities | 364 | — | 364 | — | |||||||||||||||||||
| Municipal securities | 159 | — | 159 | — | |||||||||||||||||||
| U.S. Treasury notes | 20 | — | 20 | — | |||||||||||||||||||
Other | 47 | — | 47 | — | |||||||||||||||||||
| Total assets | $ | 4,008 | $ | — | $ | 4,008 | $ | — | |||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Corporate debt securities | $ | 2,744 | $ | — | $ | 2,744 | $ | — | |||||||||||||||
| Mortgage-backed securities | 914 | — | 914 | — | |||||||||||||||||||
| Asset-backed securities | 431 | — | 431 | — | |||||||||||||||||||
| Municipal securities | 183 | — | 183 | — | |||||||||||||||||||
| U.S. Treasury notes | 5 | — | 5 | — | |||||||||||||||||||
Other | 48 | — | 48 | — | |||||||||||||||||||
| Total assets | $ | 4,325 | $ | — | $ | 4,325 | $ | — | |||||||||||||||
| December 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
| Carrying Amount | Fair Value | Carrying Amount | Fair Value | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
4.375% Notes due 2028 | $ | 797 | $ | 786 | $ | 795 | $ | 759 | |||||||||||||||
3.875% Notes due 2030 | 646 | 603 | 645 | 578 | |||||||||||||||||||
6.500% Notes due 2031 | 838 | 873 | — | — | |||||||||||||||||||
3.875% Notes due 2032 | 744 | 682 | 743 | 648 | |||||||||||||||||||
6.250% Notes due 2033 | 741 | 764 | 740 | 741 | |||||||||||||||||||
| Total | $ | 3,766 | $ | 3,708 | $ | 2,923 | $ | 2,726 | |||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 10, 2026 | Showing above |
| 2024 | Feb 11, 2025 | |
| 2023 | Feb 13, 2024 | |
| 2022 | Feb 13, 2023 | |
| 2021 | Feb 14, 2022 | |
| 2020 | Feb 16, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2018 | Feb 19, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Feb 26, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.